Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GABRB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SH3KBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GEO DataSets Gene Profile neighbors
KCNIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYRFL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIMBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THOC7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERVH-6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLI4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AIG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR7E19P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHLDB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSGALNACT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RLIM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPRYD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on